Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
1 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
1 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
34701
-
34702
-
34703
-
34704
-
34705
-
34706
-
34707
-
34708
-
34709
The cell viability of C35 siRNA1-treated breast ductal carcinoma cells after C35 gene was overexpressed.
Published 2017“…The decreased viability in C35 siRNA1-treated BT-474 cells was restored after C35 was overexpressed at 48 h. ** indicates that <i>p</i> < 0.01 as compared with the control group. ## indicates that <i>p</i> < 0.01 as compared with siRNA1 group alone.…”
-
34710
Supplementary Material for: Impact of the national action plan for antimicrobial resistance on antibiotic use for mastitis using a Japanese nationwide database
Published 2023“…The trend of broad-spectrum antibiotics administration significantly changed at the publication (-2,6% [95% confidence interval, -3.9% to -1.3%], P<0.001) and the administration decreased after the publication (1.9% annual decrease, Ptrend<0.001). …”
-
34711
-
34712
-
34713
-
34714
DataSheet_1_The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass.docx
Published 2023“…</p>Results<p>In propensity-matched patients, the 30-day mortality (16% vs 24%, P=0.32), stroke (2% vs 8%, P=0.17), ECMO(6% vs 10%, P=0.46), IABP(4% vs 8%, P=0.40) and CRRT(8% vs 20%, P=0.08) had no differences between sivelestat and control group; sivelestat could significantly decrease pneumonia (40% vs 62%, P=0.03), mechanical ventilation time (median: 96hours, IQR:72-120hours vs median:148hours, IQR:110-186hours, P<0.01), bilateral pulmonary infiltrates (P<0.01), oxygen index (P<0.01), interleukin-6(P=0.02), procalcitonin(P<0.01) and C-reactive protein(P<0.01).…”
-
34715
DataSheet_1_The neutrophil elastase inhibitor, sivelestat, attenuates acute lung injury in patients with cardiopulmonary bypass.docx
Published 2023“…</p>Results<p>In propensity-matched patients, the 30-day mortality (16% vs 24%, P=0.32), stroke (2% vs 8%, P=0.17), ECMO(6% vs 10%, P=0.46), IABP(4% vs 8%, P=0.40) and CRRT(8% vs 20%, P=0.08) had no differences between sivelestat and control group; sivelestat could significantly decrease pneumonia (40% vs 62%, P=0.03), mechanical ventilation time (median: 96hours, IQR:72-120hours vs median:148hours, IQR:110-186hours, P<0.01), bilateral pulmonary infiltrates (P<0.01), oxygen index (P<0.01), interleukin-6(P=0.02), procalcitonin(P<0.01) and C-reactive protein(P<0.01).…”
-
34716
-
34717
-
34718
-
34719
-
34720